Devising a pathway for hyaluronan catabolism: Are we there yet?

Glycobiology

Volumn 13, Issue 12, 2003, Pages

  Stern, Robert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

endoglycosidases; exoglycosidases; CD44; Hyaluronan; Hyaluronidase

Indexed keywords

ACETYLGLUCOSAMINIDASE; BETA GLUCURONIDASE; BINDING PROTEIN; GLYCOSAMINOGLYCAN; GLYCOSIDASE; HYALURONIC ACID; HYALURONIDASE; POLYMER; RECEPTOR;

CANCER CELL; CARBOHYDRATE ANALYSIS; CATABOLISM; CELL FUNCTION; CELL NUCLEUS; CELL ORGANELLE; CELL SURFACE; CELLULAR DISTRIBUTION; CHEMICAL INTERACTION; CYTOPLASM; DEGRADATION; ENDOSOME; ENZYME ACTIVITY; ENZYME MECHANISM; EXTRACELLULAR MATRIX; HUMAN; LYSOSOME; METASTASIS; MOLECULAR WEIGHT; MULTIGENE FAMILY; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN INDUCTION; REVIEW; SIGNAL TRANSDUCTION; SURFACE CHARGE; TUMOR GROWTH; TURNOVER TIME;

ANIMALS; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; NEOPLASMS;

VERTEBRATA;

EID: 0344668719     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/cwg112     Document Type: Review

References (140)

1. Afify, A.M., Stern, M., Guntenhoener, M., and Stern, R. (1993) Purification and characterization of human serum hyaluronidase. Arch. Biochem. Biophys., 305, 434-441.
2. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., and Clarke, M.F. (2003) Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA, 100, 3983-3988.
3. Baba, D., Kashiwabara, S., Honda, A., Yamagata, K., Wu, Q., Ikawa, M., Okabe, M., and Baba,T. (2002) Mouse sperm lacking cell surface hyaluronidase PH-20 can pass through the layer of cumulus cells and fertilize the egg. J. Biol. Chem., 277, 30310-30314.
4. Banhegyi, G. and Mandl, J. (2001) The hepatic glycogenoreticular system. Pathol. Oncol. Res., 7, 107-110.
5. Baumgartner, G. and Neumann, H. (1987) [Hyaluronidase in cytostatic therapy of ENT tumors]. Laryngol. Rhinol. Otol. (Stuttg.), 66, 195-199.
6. Bazel, S. and Alhadeff, J.A. (1999) Characterization of purified cathepsin D from malignant human breast tissue. Int. J. Oncol., 14, 315-319.
7. Becherer, J.D. and Blobel, C.P. (2003) Biochemical properties and functions of membrane-anchored metalloprotease-distintegrin proteins (ADAMs). Curr. Top. Dev. Biol., 54, 101-123.
8. Beckenlehner, K., Bannke, S., Spruss, T., Bernhardt, G., Schonenberg, H., and Schiess, W. (1992) Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo. J. Cancer Res. Clin. Oncol., 118, 591-596.
9. Beeber, C. and Kieras, F.J. (2002) Characterization of the chondroitin sulfates in wild type Caenorhabditis elegans. Biochem. Biophys. Res. Commun., 293, 1374-1376.
10. Beech, D.J., Madan, A.K., and Deng, N. (2002) Expression of PH-20 in normal and neoplastic breast tissue. J. Surg. Res., 103, 203-207.
11. Bourguignon, L.Y., Zhu, H., Shao, L., and Chen, Y.W. (2001) CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J. Biol. Chem., 276, 7327-7336.
12. Brecht, M., Mayer, U., Schlosser, E., and Prehm, P. (1986) Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem. J., 239, 445-450.
13. Chain, E. and Duthie, E.S. (1940) Identity of hyaluronidase and spreading factor. Br. J. Expl. Path., 21, 324-338.
14. Chang, N.S. (2002) Transforming growth factor-beta1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts. BMC Cell Biol, 3, 8.
15. Cherr, G.N., Meyers, S.A., Yudin, A.I., VandeVoort, C.A., Myles, D.G., Primakoff, P., and Overstreet, J.W. (1996) The PH-20 protein in cynomolgus macaque: identification of two different forms exhibiting hyaluronidase activity. Dev. Biol., 175, 142-153.
16. Cherr, G.N., Yudin, A.I., and Overstreet, J.W. (2001) The dual functions of GPI-anchored PH-20: hyaluronidase and intracellular signaling. Matrix Biol., 20, 515-525.
17. Cheung, W.F., Cruz, T.F., and Turley, E.A. (1999) Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors. Biochem. Soc. Trans., 27, 135-142.
18. Collis, L., Hall, C., Lange, L., Ziebell, M., Prestwich, R., and Turley, E. A. (1998) Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action. FEBS Lett., 440, 444-449.
19. Comtesse, N., Maldener E., and Meese, E. (2001) Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase and a beta-N-acetylglucosaminidase. Biochem. Biophys. Res. Commun., 283, 634-640.
20. Csoka, T.B., Frost, G.I., and Stern, R. (1997a) Hyaluronidases in tissue invasion. Inv. Metastasis, 17, 297-311.
21. Csoka, A.B., Frost, G.I., Wong, T., and Stern, R. (1997b) Purification and microsequencing of hyaluronidase isozymes from human urine. FEBS Lett., 417, 307-310.
22. Csoka, T.B., Frost, G.I., Heng, H.H., Scherer, S.W., Mohapatra, G., and Stern R. (1998) The hyaluronidase gene HYAL1 maps to chromosome 3p21.2-p21.3 in human and 9F1-F2 in mouse, a conserved candidate tumor suppressor locus. Genomics, 48, 63-70.
23. Csoka, A.B., Scherer, S.W., and Stern, R. (1999) Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31. Genomics, 60, 356-361.
24. Csoka, A.B., Frost, G.I., and Stern, R. (2001) The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol., 20, 499-508.
25. Culty, M., Nguyen, H.A., and Underhill, C.B. (1992) The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J. Cell Biol., 116, 1055-1062.
26. Day, A.J. and Sheehan JK. (2001) Hyaluronan: polysaccharide chaos to protein organisation. Curr. Opin. Struct. Biol., 11, 617-622.
27. DeAngelis, P.L., Jing, W., Graves, M.V., Burbank, D.E., and Van Etten, J.L. (1997) Hyaluronan synthase of chlorella virus PBCV-1. Science, 278, 1800-1803.
28. Decker, M., Chiu, E.S., Moin, A., Spendlove, R., Longaker, M., and Stern, R. (1989) A hyaluronic acid-stimulating factor in fetal bovine and breast cancer patient sera. Cancer Res., 49, 3499-3505.
29. Dehal, P., Satou, Y., Campbell, R.K., Chapman, J., Degnan, B., DeTomaso, A., Davidson, B., DiGregorio, A., Gelpke, M., Goodstein, D.M., and others. (2002) The draft genome of Ciona intestinalis: insights into chordate and vertebrate origins. Science, 298, 2157-2167.
30. Delmage, J.M., Powars, D.R., Jaynes, P.K., and Allerton, S.E. (1986) The selective suppression of immunogenicity by hyaluronic acid. Ann. Clin. Lab. Sci., 16, 303-310.
31. Deng, X., He, Y., and Martin-Deleon, P.A. (2000) Mouse Spam1 (PH-20): evidence for its expression in the epididymis and for a new category of spermatogenic-expressed genes. J. Androl., 21, 822-832.
32. De Salegui, M. and Pigman, W. (1967) The existence of an acid-active hyaluronidase in serum. Arch. Biochem. Biophys., 120, 60-67.
33. Duran-Reynals, F. (1928) Exaltation de l'activité du virus vaccinal par les extraits de certains organs. CR Soc. Biol., 99, 6-7.
34. Edelson, M.I., Scherer, S.W., Tsui, L.C., Welch, W.R., Bell, D.A., Berkowitz, R.S., and Mok, S.C. (1997) Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas. Oncogene, 14, 2979-2984.
35. Entwistle, J., Hall, C.L., and Turley, E.A. (1996) HA receptors: regulators of signalling to the cytoskeleton. J. Cell Biochem., 61, 569-577.
36. Evanko, S.P. and Wight, T.N. (1999) Intracellular localization of hyaluronan in proliferating cells. J. Histochem. Cytochem., 47, 1331-1342.
37. Evanko, S.P., Angello, J.C., and Wight, T.N. (1999) Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol., 19, 1004-1013.
38. Feinberg, R.N. and Beebe, D.C. (1983) Hyaluronate in vasculogenesis. Science, 220, 1177-1179.
39. Flannery, C.R., Little, C.B., Hughes, C.E., and Caterson, B. (1998) Expression and activity of articular cartilage hyaluronidases. Biochem. Biophys. Res. Commun., 251, 824-829.
40. Folkman, J. (2002) Role of angiogenesis in tumor growth and metastasis. Semin. Oncol., 29, 15-18.
41. Fraser, J.R., Laurent, T.C., Pertoft, H., and Baxter, E. (1981) Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem. J., 200, 415-424.
42. Frost, G.I. and Stern, R. (1997) A microtiter-based assay for hyaluronidase activity not Requiring specialized reagents. Anal. Biochem., 251, 263-269.
43. Frost, G.I., Csoka, T., and Stern, R. (1996) The hyaluronidases: a chemical, biological and clinical overview. Trends Glycosci. Glycotech., 8, 419-434.
44. Frost, G.I., Csoka, T.B., Wong, T., and Stern R. (1997) Purification, cloning and expression of human plasma hyaluronidase. Biochem. Biophys. Res. Commun., 236, 10-15.
45. LUCA-1, a candidate tumor suppressor gene on chromosome 3p21.3, is inactivated in head and neck squamous cell carcinomas by aberrant splicing of pre-mRNA. Oncogene, 19, 870-877.
46. Ghatak, S., Misra, S., and Toole, B.P. (2002) Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J. Biol. Chem., 277, 38013-38020.
47. Godin, D.A., Fitzpatrick, P.C., Scandurro, A.B., Belafsky, P.C., Woodworth, B.A., Amedee, R.G., Beech, D.J., and Beckman, B.S. (2000) PH20: a novel tumor marker for laryngeal cancer. Arch. Otolaryngol. Head Neck Surg., 126, 402-404.
48. Graves, M.V., Burbank, D.E., Roth, R., Heuser, J., DeAngelis, P.L., and Van Etten, J.L. (1999) Hyaluronan synthesis in virus PBCV-1-infected chlorella-like green algae. Virology, 257, 15-23.
49. Heckel, D., Comtesse, N., Brass, N., Blin, N., Zang, K.D., and Meese, E. (1998) Novel immunogenic antigen homologous to hyaluronidase in meningioma. Hum. Mol. Genet., 7, 1859-1872.
50. Henry, C.B. and Duling, B.R. (1999) Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am. J. Physiol., 277, H508-H514.
51. Hernandez, J.M., Schoenmakers, E.F., Dal Cin, P., Michaux, L., Van de Ven, W.J., and Van Den Berghe, H. (1997) Molecular delineation of the commonly deleted segment mature B cell lymphoid neoplasias with deletion of 7q. Genes Chromosomes Cancer, 18, 147-150.
52. Hiltunen, E.L., Anttila, M., Kultti, A., Ropponen, K., Penttinen, J., Yliskoski, M., Kuronen, A.T., Juhola, M., Tammi, R., Tammi, M., and Kosma, V.M. (2002) Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors. Cancer Res., 62, 6410-6413.
53. Hirotsune, S., Yoshida, N., Chen, A., Garrett, L., Sugiyama, F., Takahashi, S., Yagami, K., Wynshaw-Boris, A., and Yoshiki, A. (2003) An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene. Nature, 423, 91-96.
54. Hovingh, P. and Linker, A. (1999) Hyaluronidase activity in leeches (Hirudinea). Comp. Biochem. Physiol. B Biochem. Mol. Biol., 124, 319-326.
55. Hua, Q., Knudson, C.B., and Knudson, W. (1993) Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J. Cell Sci., 106, 365-375.
56. Huey, G., Moiin, A., and Stern, R. (1990) Deposition of hyaluronic acid by fibroblasts is modulated by culture conditions. Matrix Biol., 10, 75-81.
57. Ishimoto, N., Temin, H.M., and Strominger, J.L. (1966) Studies of carcinogenesis by avian sarcoma viruses. II. Virus-induced increase in hyaluronic acid synthetase in chicken fibroblasts. J. Biol. Chem., 241, 2052-2057.
58. Itano, N. and Kimata, K. (2002) Mammalian hyaluronan synthases. IUBMB Life, 54, 195-199.
59. Itano, N., Sawai, T., Yoshida, M., Lenas, P., Yamada, Y., Imagawa, M., Shinomura, T., Hamaguchi, M., Yoshida, Y., Ohnuki, Y., and others. (1999) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J. Biol. Chem., 274, 25085-25092.
60. Jacobson, A., Rahmanian, M., Rubin, K., and Heldin, P. (2002) Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors. Int. J. Cancer, 102, 212-219.
61. Ji, L., Nishizaki, M., Gao, B., Burbee, D., Kondo, M., Kamibayashi, C., Xu, K., Yen N, Atkinson, E.N., Fang, B., and others. (2002) Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res., 62, 2715-2720.
62. Karlstam, B. and Ljungloef, A. (1991) Purification and partial characterization of a novel hyaluronic acid-degrading enzyme from Antarctic krill (Euphasia superba). Polar Biol., 11, 501-507.
63. Karlstam, B., Vincent, J., Johansson, B., and Bryno, C. (1991) A simple purification method of squeezed krill for obtaining high levels of hydrolytic enzymes. Prep. Biochem., 21, 237-256.
64. Kaya, G., Rodriguez, I., Jorcano, J.L., Vassalli, P., and Stamenkovic, I. (1997) Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev., 11, 996-1007.
65. Klocker, J., Sabitzer, H., Raunik, W., Wieser, S., and Schumer, J. (1998) Hyaluronidase as additive to induction chemotherapy in advanced squamous cell carcinoma of the head and neck. Cancer Lett., 131, 113-115.
66. Knudson, C.B. and Knudson, W. (1993) Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J., 7, 1233-1241.
67. Kreil, G. (1995) Hyaluronidases - a group of neglected enzymes. Protein Sci., 4, 1666-1669.
68. Kujawa, M.J., Pechak, D.G., Fiszman, M.Y., and Caplan, A.I. (1986) Hyaluronic acid bonded to cell culture surfaces inhibits the program of myogenesis. Dev. Biol., 113, 10-16.
69. Larnier, C., Kerneur, C., Robert, L., and Moczar, M. (1989) Effect of testicular hyaluronidase on hyaluronate synthesis by human skin fibroblasts in culture. Biochim. Biophys. Acta, 1014, 145-152.
70. Laurent, T.C. (1998) The chemistry, biology and medical applications of hyaluronan and its derivatives. Portland Press, London.
71. Lee, J.Y. and Spicer, A.P. (2000) Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr. Opin. Cell Biol., 12, 581-586.
72. Lepperdinger, G., Strobl, B., and Kreil, G. (1998) HYAL2, a human gene expressed in manycells, encodes a lysosomal hyaluronidase with a novel type of specificity. J. Biol. Chem., 273, 22466-22470.
73. Lepperdinger, G., Mullegger, J., and Kreil, G. (2001) Hyal2 - less active, but more versatile? Matrix Biol., 20, 509-514.
74. Lerman, M.I. and Minna, J.D., (2000) The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res., 60, 6116-6133.
75. Lin, W., Shuster, S., Maibach, H.I., and Stern R. (1997) Patterns of hyaluronan staining are modified by fixation techniques. J. Histochem. Cytochem., 45, 1157-1163.
76. Lokeshwar, V.B., Rubinowicz, D., Schroeder, G.L., Forgacs, E., Minna, J.D., Block, N.L., Nadji, M., and Lokeshwar, B.L. (2001) Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J. Biol. Chem., 276, 11922-11932.
77. Longaker, M.T., Chiu, E.S., Adzick, N.S., Stern, M., Harrison, M.R., and Stern, R. (1991) Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann. Surg., 213, 292-296.
78. Madan, A.K., Pang, Y., Wilkiemeyer, M.B., Yu, D., and Beech, D.J. (1999a) Increased hyaluronidase expression in more aggressive prostate adenocarcinoma. Oncol. Rep., 6, 1431-1433.
79. Madan, A.K., Yu, K., Dhurandhar, N., Cullinane, C., Pang, Y., and Beech, D.J. (1999b) Association of hyaluronidase and breast adenocarcinoma invasiveness. Oncol. Rep., 6, 607-609.
80. Maeda, N., Palmarini, M., Murgia, C., and Fan, H. (2001) Direct transformation of rodent fibroblasts by jaagsiekte sheep retrovirus DNA. Proc. Natl Acad. Sci. USA, 98, 4449-4454.
81. Maeyer, E. and De Maeyer-Guignard, J. (1992) The growth rate of two transplantable murine tumors, 3LL lung carcinoma and B16F10 melanoma, is influenced by Hyal-1, a locus determining hyaluronidase levels and polymorphism. Int. J. Cancer, 51, 657-660.
82. Maier, U. and Baumgartner, G. (1989) Metaphylactic effect of mitomycin C with and without hyaluronidase after transurethral resection of bladder cancer: randomized trial. J. Urol., 141, 529-530.
83. Majumdar, M., Meenakshi, J., Goswami, S.K., and Datta, K. (2002) Hyaluronan binding protein 1 (HABP1)/C1QBP/p32 is an endogenous substrate for MAP kinase and is translocated to the nucleus upon mitogenic stimulation. Biochem. Biophys. Res. Commun., 291, 829-837.
84. Markovic-Housley, Z., Miglierini, G., Soldatova, L., Rizkallah, P.J., Muller, U., and Schirmer, T. (2000) Crystal structure of hyaluronidase, a major allergen of bee venom. Structure Fold Des., 8, 1025-1035.
85. Mateo, M., Mollejo, M., Villuendas, R., Algara, P., Sanchez-Beato, M., Martinez, P., and Piris, M.A. (1999) 7q31-32 Allelic loss is a frequent finding in splenic marginal zone lymphoma. Am. J. Pathol., 154, 1583-1589.
86. McBride, W.H. and Bard, J.B. (1979) Hyaluronidase-sensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis. J. Exp. Med., 149, 507-515.
87. Meyer, M.F., Kreil, G., and Aschauer, H. (1997) The soluble hyaluronidase from bull testes is a fragment of the membrane-bound PH-20 enzyme. FEBS Lett., 413, 385-388.
88. Meyer, K. (1971) Hyaluronidases. In Boyer, P.D. (Ed.), The Enzymes, vol. 5. Academic Press, New York, pp. 307-320.
89. Mian, N. (1986a) Analysis of cell-growth-phase-related variations in hyaluronate synthase activity of isolated plasma-membrane fractions of cultured human skin fibroblasts. Biochem. J., 237, 333-342.
90. r plasma-membrane-bound protein and assessment of its role as a constituent of hyaluronate synthase complex. Biochem. J., 237, 343-357.
91. Mio, K. and Stern, R. (2002) Inhibitors of the hyaluronidases. Matrix Biol., 21, 31-37.
92. Mio, K., Carrette, O., Maibach, H.I., and Stern, R. (2000) Evidence that the serum inhibitor of hyaluronidase may be a member of the inter-α-inhibitor family. J. Biol. Chem. 275, 32413-32421.
93. Myint, P., Deeble, D.J., Beaumont, P.C., Blake, S.M., and Phillips, G.O. (1987) The reactivity of various free radicals with hyaluronic acid: steady-state and pulse radiolysis studies. Biochim. Biophys. Acta, 925, 194-202.
94. Myles, D.G. and Primakoff, P. (1997) Why did the sperm cross the cumulus? To get to the oocyte. Functions of the sperm surface proteins PH-20 and fertilin in arriving at, and fusing with, the egg. Biol Reprod., 56, 320-327.
95. Natowicz, M.R. and Wang, Y. (1996) Plasma hyaluronidase activity in mucolipidoses II and III: marked differences from other lysosomal enzymes. Am. J. Med. Genet., 65, 209-212.
96. Natowicz, M.R., Short, M.P., Wang, Y., Dickersin, G.R., Gebhardt, M.C., Rosenthal, D.I., Sims K.B., and Rosenberg, A.E. (1996) Clinical and biochemical manifestations of hyaluronidase deficiency. N. Engl. J. Med., 335, 1029-1033.
97. Nicoll, S.B., Barak, O., Csoka, A.B., Bhatnagar, R.S., and Stern, R. (2002) Hyaluronidases and CD44 undergo differential modulation during chondrogenesis. Biochem. Biophys. Res. Commun., 292, 819-825.
98. Noble, P.W. (2002) Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol., 21, 25-29.
99. Novak, U., Stylli, S.S., Kaye, A.H., and Lepperdinger, G. (1999) Hyaluronidase-2 overexpression accelerates intracerebral but not subcutaneous tumor formation of murine astrocytoma cells. Cancer Res., 59, 6246-6250.
100. Oettl, M., Hoechstetter, J., Asen, I., Bernhardt, G., and Buschauer, A. (2003) Comparative characterization of bovine testicular hyaluronidase and a hyaluronate from Streptococcus agalactiae in pharmaceutical preparations. Eur. J. Pharm. Sci., 18, 267-277.
101. Pasonen-Seppanen, S., Karvinen, S., Torronen, K., Hyttinen, J.M., Jokela, T., Lammi, M.J., Tammi, M.I., and Tammi, R. (2003) EGF upregulates, whereas TGF-beta downregulates, the hyaluronan synthases Has2 and Has3 in organotypic keratinocyte cultures: correlations with epidermal proliferation and differentiation. J. Invest. Dermatol., 120, 1038-1044.
102. Pawlowski, A., Haberman, H.F., and Menon, I.A. (1979) The effects of hyaluronidase upon tumor formation in BALB/C mice painted with 7,12-dimethylbenz-(a)anthracene. Int. J. Cancer, 23, 105-109.
103. Philipson, L.H. and Schwartz, N.B. (1984) Subcellular localization of hyaluronate synthetase in oligodendroglioma cells. J. Biol. Chem., 259, 5017-5023.
104. Philipson, L.H., Westley, J., and Schwartz, N.B. (1985) Effect of hyaluronidase treatment of intact cells on hyaluronate synthetase activity. Biochemistry, 24, 7899-7906.
105. Pratt, R.M., Larsen, M.A., and Johnston, M.C. (1975) Migration of cranial neural crest cells in a cell-free hyaluronate-rich matrix. Dev Biol., 44, 298-305.
106. Prehm, P. (1980) Induction of hyaluronic acid synthesis in teratocarcinoma stem cells by retinoic acid. FEBS Lett., 111, 295-298.
107. Prehm, P. (1984) Hyaluronate is synthesized at plasma membranes. Biochem. J., 220, 597-600.
108. Rai, S.K., Duh, F.M., Vigdorovich, V., Danilkovitch-Miagkova, A., Lerman, I., and Miller, A.D. (2001) Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc. Natl Acad. Sci. USA, 98, 4443-4448.
109. Renkema, G.H., Boot, R.G., Strijland, A., Donker-Koopman, W.E, van den Berg, M., Muijsers, A.O., and Aerts, J.M. (1997) Synthesis, sorting, and processing into distinct isoforms of human macrophage chitotriosidase. Eur. J. Biochem., 244, 279-285.
110. Rigden, D.J., Galperin, M.Y., and Jedrzejas, M.J. (2003a) Analysis of structure and function of putative surface-exposed proteins encoded in the Streptococcus pneumoniae genome: a bioinformatics-based approach to vaccine and drug design. Crit. Rev. Biochem. Mol. Biol., 38, 143-168.
111. Rigden, D.J., Jedrzejas, M.J., and de Mello, L.V. (2003b) Identification and analysis of catalytic TIM barrel domains in seven further glycoside hydrolase families. FEBS Lett., 544, 103-111.
112. Scott, J.E. and Heatley, F. (2002) Biological properties of hyaluronan in aqueous solution are controlled and sequestered by reversible tertiary structures, defined by NMR spectroscopy. Biomacromolecules, 3, 547-553.
113. Shearer, J. and Graham, T.E. (2002) New perspectives on the storage and organization of muscle glycogen. Can. J. Appl. Physiol., 27, 179-203.
114. Shuster, S., Frost, G.I., Csoka, A.B., Formby, B., and Stern, R. (2002) Hyaluronidase treatment reduces tumor size in human xenografts in SCID mice. Int. J. Cancer, 102, 192-197.
115. Stein, L.D. (1999) Internet access to the C. elegans genome. Trends Genet., 15, 425-427.
116. Stern, M. and Stern, R. (1992) A collagenous sequence in a prokaryotic hyaluronidase. Mol. Biol. Evol., 9, 1179-1180.
117. Stern, R., Shuster, S., Wiley, T.S., and Formby, B. (2001) Hyaluronidase can modulate expression of CD44. Exp. Cell Res., 266, 167-176.
118. Stern, R., Shuster, S., Neudecker, B.A., and Formby, B. (2002) Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited. Exp. Cell Res., 276, 24-31.
119. Tammi, R., Rilla, K., Pienimaki, J.P., MacCallum, D.K., Hogg, M., Luukkonen, M., Hascall, V.C., and Tammi, M. (2001) Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J. Biol. Chem., 276, 35111-35122.
120. Tanabe, K.K., Nishi, T., and Saya, H. (1993) Novel variants of CD44 arising from alternative splicing: changes in the CD44 alternative splicing pattern of MCF-7 breast carcinoma cells treated with hyaluronidase. Mol. Carcinog., 7, 212-220.
121. Termeer, C.C., Hennies, J., Voith, U., Ahrens, T., Weiss, J.M., Prehm, P., and Simon, J.C. (2000) Oligosaccharides of hyaluronan are potent activators of dendritic cells. J. Immunol., 165, 1863-1870.
122. Termeer, C., Sleeman, J.P., and Simon, J.C. (2003) Hyaluronan - magic glue for the regulation of the immune response? Trends Immunol., 24, 112-114.
123. Tomida, M., Koyama, H., and Ono, T. (1974) Hyaluronate acid synthetase in cultured mammalian cells producing hyaluronic acid: oscillatory change during the growth phase and suppression by 5-bromodeoxyuridine. Biochim. Biophys. Acta, 338, 352-363.
124. Tomida, M., Koyama, H., and Ono, T. (1976) A serum factor capable of stimulating hyaluronic acid synthesis in cultured rat fibroblasts. J. Cell Physiol., 91, 323-328.
125. Toole, B.P. (1990) Hyaluronan and its binding proteins, the hyaladherins. Curr. Opin. Cell Biol., 2, 839-844.
126. Toole, B.P. (1991) Proteoglycans and hyaluronan in morphogenesis and differentiation. In Hay, E.D. (Ed.), Cell biology of extracellular matrix. Plenum Press, New York, pp. 61-92.
127. Toole, B.P. (2000) Hyaluronan is not just a goo! J. Clin. Invest., 106, 335-336.
128. Toole, B.P. (2001) Hyaluronan in morphogenesis. Semin. Cell Dev. Biol., 12, 79-87.
129. Toole, B.P. (2002) Hyaluronan promotes the malignant phenotype. Glycobiology, 12, 37R-42R.
130. Toole, B.P. and Hascall, V.C. (2002) Hyaluronan and tumor growth. Am. J. Pathol., 161, 745-747.
131. Triggs-Raine, B., Salo, T.J., Zhang, H., Wicklow, B.A., and Natowicz, M.R. (1999) Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder,mucopolysaccharidosis IX. Proc. Natl Acad. Sci. USA, 96, 6296-6300.
132. Uchiyama, H., Dobashi, Y., Ohkouchi, K., and Nagasawa, K. (1990) Chemical change involved in the oxidative reductive depolymerization of hyaluronic acid. J. Biol. Chem., 265, 7753-7759.
133. Weigel, P.H., Hascall, V.C., and Tammi, M. (1997) Hyaluronan synthases. J. Biol. Chem., 272, 13997-14000.
134. Wernicke, M., Pineiro, L.C., Caramutti, D., Dorn, V.G., Raffo, M.M., Guixa, H.G., Telenta, M., and Morandi, A.A. (2003) Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan. Mod. Pathol., 16, 99-107.
135. West, D.C., Hampson, I.N., Arnold, F., and Kumar, S. (1985) Angiogenesis induced by degradation products of hyaluronic acid. Science, 228, 1324-1326.
136. Xu, H., Ito, T., Tawada, A., Maeda, H., Yamanokuchi, H., Isahara, K., Yoshida, K., Uchiyama Y., and Asari, A. (2002) Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. J. Biol. Chem., 277, 17308-17314.
137. Yamada, S., Van Die, I., Van den Eijnden, D.H., Yokota, A., Kitagawa, H., and Sugahara, K. (1999) Demonstration of glycosaminoglycans in Caenorhabditis elegans. FEBS Lett., 459, 327-331.
138. Zahalka, M.A., Okon, E., Gosslar, U., Holzmann, B., and Naor, D. (1995) Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronatedependent. J. Immunol., 154, 5345-5355.
139. Zenklusen, J.C. and Conti, C.J. (1996) Cytogenetic, molecular and functional evidence for novel tumor suppressor genes on the long arm of human chromosome 7. Mol. Carcinog., 15, 167-175.
140. Zhang, H. and Martin-DeLeon, P.A. (2003) Mouse Spam1 (PH-20) is a multifunctional protein: evidence for Its expression in the female reproductive tract. Biol Reprod., forthcoming.